Since the your new batman avatar appeared your posts have...

First 1572 Last

Share
Profile

Follow
scibble

53 Posts.

34

09/08/18

16:24

Post #: 34837983
Share

Originally posted by MarketingMan ↑

Further, to other posts.

In the next few months, we are expecting PEA, OT and revised JORC and probably an announcement confirming increased production tonnage from the pilot plant (rated at 500 tonnes per year) as clear indication that AGY is now a producer.

This will give the market solid (and independent) expected financial performance data.
We are anticipating good results.

Leaving aside possible adverse market events (e.g. a decline in the Lithium market or Trump doing something silly) or something going wrong at AGY, these announcements show potential for strong sentiment capable of pushing the price to near $1.00 (my belief).

Toward the end of this year AGY is expected to release firmed-up plans about expanding their primary processing capability (converting brine to Lithium) and there is the distinct possibility (suggested by MD Jerko Z) that they may skip the Stage 2 plant and go straight to building Stage 3.

The key catalyst for this would be strong financial support (probably a combination of up-front payment for product combined with a debt finance instrument) from a strategic customer (a battery maker or big auto trying to firm-up supply).

This announcement (or even commencing building the smaller Stage 2 plant option) will have a strong affect on the share price. My opinion is that AGY will then push well into dollar territory. This could happen somewhere between November 2018 and March next year.

Given the remarkable achievement being one of the few aspiring Lithium brine operations to achieve battery grade capability in the last 20 years, we expect AGY to be much sort after by both Lithium customers and potentially other brine producers seeking access to AGY's technology.

Therefore, a range of (as yet) unknown possible deals could be in the wind; while this is speculation, it is also a real possibility.

Many here expect that within 2 to 3 years, AGY will look a bit like Orocobre Ltd ORE:ASX, currently trading at circa $4.50

I offer this information purely as my opinion and you should read through the many posts (pick the ones with +30 thumbs-up) under "fundamentals" to see if you find verification before making your investment decision.

Good luck

Expand

Since the your new batman avatar appeared your posts have changed tone,

You have of late been showing the ability to get valid and valuable information out in a easy to understand way without the emotional edge

I am enjoying the change Marketing (maybe the real Batman) Man

Appreciate your posts

AGY Price at posting: 26.0¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

There are more pages in this discussion • 1,152 more messages in this thread...

First 1572 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 8.8¢		Change 0.000(0.00%)		Mkt cap ! $128.1M

Open	High	Low	Value	Volume
8.8¢	8.9¢	8.6¢	$36.10K	414.1K

Buyers (Bids)

No.	Vol.	Price($)
2	37936	8.6¢

Sellers (Offers)

Price($)	Vol.	No.
8.8¢	15624	1

View Market Depth

No.	Vol.	Price($)
2	37936	0.086
1	11776	0.085
2	211916	0.084
1	12000	0.083
3	154841	0.082

Price($)	Vol.	No.
0.088	15624	1
0.090	34601	2
0.091	381389	1
0.092	119587	3
0.093	211655	3

Last trade - 16.10pm 09/07/2024 (20 minute delay)

AGY (ASX) Chart

Since the your new batman avatar appeared your posts have...

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Since the your new batman avatar appeared your posts have...

Top Stories

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News